T3 Drugs Doses

Initially 6mg rapid IV/IO bolus, may repeat at 12mg

Initially 0.1mg/kg rapid IV/IO bolus (up to 6mg), may repeat at 0.2mg/kg (up to 12mg)

2.5mg nebulized over several minutes, may repeat continuously based on individual need and side effect profile.

If given as a "blow-by" treatment may administer adult dose. If given as a maked nebulizer or via a colosed circuit system (ex in-line nebulizer on a ventilated pt) 0.625mg - 0.125mg over several minutes. Increased dosing may be used in any child in severe distress or known drug tolerance.

• PEA B-Tach or V-Fib: 300mg IV/IO. If successful then continuous infusion.
• Unstable V-Tach w/ a pulse: 150mg diluted in 50-100cc's NSS admin over 10 minutes, if successful then a continuous infusion.
• Uncontrolled A-Fib: 150mg diluted in 50-100cc's NSS admin over 10 minutes, if successful then a continuous infusion.
• Infusion: Mix 150mg in 5 0cc D5W (will yield a 3mg/ml concentration) 1mg/min 1st 6 hours, then 0.5mg/min next 18 hours.
• (Central line preferred, use an inline particulate filter.)

• PEA B-Tach or V-Fib: 5mg IV/IO
• Unstable V-Tach w/ a pulse: 5mg/kg 10 minutes
• Infusion: Mix 150mg in 5 0cc D5W (will yield a 3mg/ml concentration) 5-10mcg/kg/min
• (Central line preferred, use an inline particulate filter.)

• Symptomatic bradycardia: 0.5mg to 1.0mg up to 3mg or 0.04mg/kg total dose.
• Organophosphate overdose: 2-5mg every 15-30 minutes as needed
• Infusion: mix 1gm in 25cc's NSS or D5W (will yield 4mg/ml concentration). 0.5-2.4mg/kg/hr titrated to suppress secretions

adjunct to RSI symptomatic bradycardia: 0.02mg/kg IVP (Minimum dose 0.1mg), may repeat once

Add 100mg to 250ml D5W/NSS (400mcg/1ml) 80-200mcg/ml